Next Article in Journal
Use of Factorial Designs to Reduce Stability Studies for Parenteral Drug Products: Determination of Factor Effects via Accelerated Stability Data Analysis
Previous Article in Journal
Population Pharmacokinetics of Tideglusib in Congenital and Childhood Myotonic Dystrophy Type 1: Influence of Demographic and Clinical Factors on Systemic Exposure
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(8), 1066; https://doi.org/10.3390/pharmaceutics17081066
Action Date Notes Link
article xml file uploaded 17 August 2025 09:16 CEST Original file -
article xml uploaded. 17 August 2025 09:16 CEST Update -
article pdf uploaded. 17 August 2025 09:16 CEST Version of Record https://www.mdpi.com/1999-4923/17/8/1066/pdf-vor
article supplementary file uploaded. 17 August 2025 09:16 CEST - https://www.mdpi.com/1999-4923/17/8/1066#supplementary
article html file updated 17 August 2025 09:17 CEST Original file -
article xml file uploaded 17 August 2025 12:18 CEST Update -
article xml uploaded. 17 August 2025 12:18 CEST Update -
article pdf uploaded. 17 August 2025 12:18 CEST Updated version of record https://www.mdpi.com/1999-4923/17/8/1066/pdf-vor
article html file updated 17 August 2025 12:20 CEST Update -
article xml file uploaded 18 August 2025 09:40 CEST Update -
article xml uploaded. 18 August 2025 09:40 CEST Update https://www.mdpi.com/1999-4923/17/8/1066/xml
article pdf uploaded. 18 August 2025 09:40 CEST Updated version of record https://www.mdpi.com/1999-4923/17/8/1066/pdf
article html file updated 18 August 2025 09:42 CEST Update https://www.mdpi.com/1999-4923/17/8/1066/html
Back to TopTop